MEI Pharma Inc

Find Ratings Reports
MEIP : NASDAQ : Health Care
$3.02 | %
Today's Range: 2.95 - 3.1
Avg. Daily Volume: 432900.0
07/21/17 - 4:00 PM ET

Financial Analysis


MEI PHARMA INC's gross profit margin for the third quarter of its fiscal year 2017 has significantly increased when compared to the same period a year ago. Even though it increased sales and net income significantly, the company was unable to grow at a faster pace than its industry competitors. MEI PHARMA INC is extremely liquid. Currently, the Quick Ratio is 11.38 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 17.04% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY17 Q3 FY16
Net Sales ($mil)4.510.0
EBITDA ($mil)-0.66-5.4
EBIT ($mil)-0.67-5.41
Net Income ($mil)-0.6-5.37


Balance Sheet Q3 FY17 Q3 FY16
Cash & Equiv. ($mil)56.7649.4
Total Assets ($mil)59.8950.93
Total Debt ($mil)0.00.0
Equity ($mil)54.946.91


Profitability Q3 FY17 Q3 FY16
Gross Profit Margin74.830.0
EBITDA Margin-14.580.0
Operating Margin-14.870.0
Sales Turnover0.380.0
Return on Assets2.07-40.74
Return on Equity2.26-44.24
Debt Q3 FY17 Q3 FY16
Current Ratio11.9312.55
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q3 FY17 Q3 FY16
Shares outstanding (mil)36.7734.16
Div / share0.00.0
EPS-0.02-0.16
Book value / share1.491.37
Institutional Own % n/a n/a
Avg Daily Volume400331.0215559.0

Valuation


SELL. MEI PHARMA INC's P/E ratio indicates a significant premium compared to an average of 40.44 for the Biotechnology industry and a significant premium compared to the S&P 500 average of 24.41. To use another comparison, its price-to-book ratio of 1.86 indicates a discount versus the S&P 500 average of 3.04 and a significant discount versus the industry average of 11.07. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
MEIP 278.00 Peers 40.44   MEIP 35.47 Peers 42.67

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

MEIP is trading at a significant premium to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

MEIP is trading at a discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
MEIP NM Peers 26.63   MEIP NM Peers 0.54

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

MEIP is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

MEIP's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
MEIP 1.86 Peers 11.07   MEIP 101.63 Peers -9.45

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

MEIP is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

MEIP is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
MEIP 4.48 Peers 176.73   MEIP NA Peers 426.84

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

MEIP is trading at a significant discount to its industry on this measurement.

 

Neutral. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

The growth rate for MEIP is not available.

 

 

Latest Stock Upgrades/Downgrades